InvestorsHub Logo
Followers 31
Posts 6445
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Wednesday, 04/19/2017 6:26:59 PM

Wednesday, April 19, 2017 6:26:59 PM

Post# of 462901
Encouraging read--from Alzheimer's Australia Facebook page--a few months old post yet still nice to read---A-2-73 ph 2/3 trial to begin by late first 1/2 of 2017 at the latest--confirmed by Caulfield Hospital-----We (The Caulfield Hospital) can confirm that ANAVEX (the biotech company that owns the molecule) is planning a large scale placebo controlled phase 3 trial to start (at latest) by mid-2017. For further updates regarding this trial please visit: www.alfredhealth.org.au or http://www.anavex.com/pipeline/anavex-2-73/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News